Related Experiment Video

Updated: Aug 25, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Fibrinogen clearance from the pulmonary interstitium

E C Meyer, R Ottaviano

    Lymphology
    |September 1, 1979
    PubMed

    Previous experiments demonstrated that 125I-human fibrinogen (125-RIF) instilled into the distal airway of the right lower lobe in intact dogs passed through the microairway into the interstitium. This report analyzed the subsequent interstitial clearance of this fibrinogen by analyzing plasma and lymph samples for 125I activity. This activity was separated into clottable, and trichloroacetic acid (TCA) insoluble and soluble components. Clottable and TCA-insoluble 125-RIF in the same ratio appeared in lymph from the right lymphatic duct (RD) and thoracic duct (TD). From standard mixing equations we calculate that 1.4 times as much lymph from the right lower lobe flows into the TD as into the RD. With one exception, clottable 125-RIF appeared in plasma only in the absence of an RD; this suggested the presence of accessory lymphatico-venous communications rather than back flux of 125-RIF at the capillary wall. By injecting 131I-human fibrinogen intravenously, we observed a small reduction in clottability (maximum of 10%) in lymph both from the RD and TD. Equilibration in RD lymph was only 1/5 as fast as albumin, and from the measured equilibration rate constant, and the assumption that interstitial fibrinogen clearance is entirely convective, we estimate that the pulmonary interstitial distribution volume for fibrinogen is 70% that for albumin. Non dialyzable 125-RIF products generated in the distal airway adhered to intracapillary, circulating erythrocytes. These products retained fibrinogen antigenicity, and appeared to be further degraded in the vascular compartment.

    More Related Videos

    Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus06:45

    Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus

    Published on: June 2, 2023

    Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting08:53

    Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

    Published on: March 28, 2025

    Related Concept Videos

    Drug Distribution: Plasma Protein Binding01:29

    Drug Distribution: Plasma Protein Binding

    Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
    Drug Elimination: The Concept of Clearance01:06

    Drug Elimination: The Concept of Clearance

    Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
    Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
    Clot Retraction and Fibrinolysis01:16

    Clot Retraction and Fibrinolysis

    After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
    Renal Clearance01:23

    Renal Clearance

    The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
    Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
    Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

    Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

    Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
    Most drugs undergo restrictive clearance, which is proportional to the...
    Hepatic Drug Clearance: Effect of Protein Binding01:09

    Hepatic Drug Clearance: Effect of Protein Binding

    Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
    For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...